Louloupi Annita, Ørom Ulf Andersson Vang
Max Planck Institute for Molecular Genetics, Berlin, Germany.
Free University of Berlin, Berlin, 14195, Germany.
Methods Mol Biol. 2018;1823:63-68. doi: 10.1007/978-1-4939-8624-8_6.
The pri-miRNA processing is important for the final regulatory role of miRNAs on the expression of their target transcripts. The processing variability between pri-miRNAs can determine the final miRNA abundance better than primary transcription itself. Thus studying the in vivo pri-miRNA biogenesis could give more insights into the contribution of each individual miRNA on regulation of gene expression. Interfering processing of a specific pri-miRNA has been challenging due to the nature of the current RNA interfence methods. Here, we describe step by step a method to arrest processing of specific pri-miRNAs in vivo using LNA microRNA Target Site Blockers. We explain in detail the various aspects of this approach that can easily be applied to different mammalian cell types. The nature of this protocol allows the in vivo study of pri-miRNA processing and processing kinetics in cells treated with different conditions, mutants, and/or cancer cell lines under physiological conditions.
初级微小RNA(pri-miRNA)的加工对于微小RNA(miRNA)最终对其靶转录本表达的调控作用至关重要。pri-miRNA之间的加工变异性比初级转录本身更能决定最终的miRNA丰度。因此,研究体内pri-miRNA的生物合成可以更深入地了解每个单独的miRNA对基因表达调控的贡献。由于当前RNA干扰方法的性质,干扰特定pri-miRNA的加工一直具有挑战性。在这里,我们逐步描述了一种使用锁核酸(LNA)微小RNA靶位点阻断剂在体内阻止特定pri-miRNA加工的方法。我们详细解释了这种方法的各个方面,这些方面可以很容易地应用于不同的哺乳动物细胞类型。该方案的性质允许在生理条件下,对用不同条件、突变体和/或癌细胞系处理的细胞中的pri-miRNA加工和加工动力学进行体内研究。